

11 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/11/3203614/0/en/BioVersys-Announces-BV100-Phase-3-Initiation-and-Provides-a-Business-Update.html

27 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/27/3139705/0/en/BioVersys-Receives-EMA-Orphan-Designation-for-the-Combination-of-Alpibectir-and-Ethionamide-for-the-Treatment-of-Tuberculosis.html